Ebola outbreak at its heart, vaccine race continues; US facility sparks protests
An Ebola outbreak continues to challenge communities, while the global race for vaccines and treatments intensifies, and a US Ebola facility in Kenya faces public protests.
Image is an AI-generated illustration, not a real photograph.
A significant Ebola outbreak, involving the Bundibugyo virus strain, is currently challenging the Democratic Republic of Congo and Uganda, prompting the World Health Organization to declare it a public health emergency of international concern in May 2026. With hundreds of confirmed cases and dozens of fatalities, the international community is urgently working to contain its spread, especially since existing Ebola vaccines are not effective against this particular strain.
In response to the urgent need, a global race for new vaccines is underway, with the Coalition for Epidemic Preparedness Innovations (CEPI) allocating substantial funding to fast-track three new vaccine candidates from IAVI, Moderna, and the University of Oxford. Clinical trials for these Bundibugyo-specific vaccines are anticipated in the coming months.
Amidst these developments, a planned U.S.-backed Ebola quarantine facility in Nanyuki, Kenya, designed to house Americans exposed to the virus, has sparked violent protests. At least two individuals have reportedly died from gunshot wounds during these demonstrations, as local residents express serious health concerns and accuse the U.S. of shifting public health risks. Despite a temporary court injunction against the facility, U.S. personnel and equipment continue to arrive, while Kenyan President William Ruto defends the project as part of national preparedness.
What each outlet emphasizes
- CNN: reports from the town at the heart of the Ebola outbreak, detailing warning signs.
- AJ: questions why a US Ebola facility in Kenya is sparking protests.
- The Guardian: provides an explainer on the race to combat Ebola, including vaccines and treatments.